Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
- PMID: 32392661
- PMCID: PMC7214357
- DOI: 10.3904/kjim.2020.139
Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm.Korean J Intern Med. 2020 Apr;35(3):550-558. doi: 10.3904/kjim.2018.282. Epub 2018 Nov 7. Korean J Intern Med. 2020. PMID: 30400679 Free PMC article.
Similar articles
-
The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.Scand J Gastroenterol. 2017 Aug;52(8):822-827. doi: 10.1080/00365521.2017.1315739. Epub 2017 Apr 22. Scand J Gastroenterol. 2017. PMID: 28436254
-
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3. Int J Cancer. 2014. PMID: 24009139
-
[Potentialities of a serological method in diagnosis of atrophic gastritis].Ter Arkh. 2008;80(2):15-21. Ter Arkh. 2008. PMID: 18372589 Russian.
-
Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.Digestion. 2016;93(1):13-8. doi: 10.1159/000441742. Epub 2016 Jan 14. Digestion. 2016. PMID: 26789514 Review.
-
Gastritis staging as a clinical priority.Eur J Gastroenterol Hepatol. 2018 Feb;30(2):125-129. doi: 10.1097/MEG.0000000000001015. Eur J Gastroenterol Hepatol. 2018. PMID: 29215433 Review.
Cited by
-
Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects.PLoS One. 2022 Oct 17;17(10):e0274938. doi: 10.1371/journal.pone.0274938. eCollection 2022. PLoS One. 2022. PMID: 36251649 Free PMC article.
-
PG I and PG II show unique value in diagnosing postoperative biochemical recurrence in patients with gastric cancer after total gastrectomy.Discov Oncol. 2024 Jun 17;15(1):231. doi: 10.1007/s12672-024-01091-0. Discov Oncol. 2024. PMID: 38884851 Free PMC article.
-
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer.J Gastrointest Oncol. 2021 Jun;12(3):1042-1048. doi: 10.21037/jgo-21-254. J Gastrointest Oncol. 2021. PMID: 34295555 Free PMC article.
-
[Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for Helicobacter pylori-Positive Early-Stage Gastric Cancer].Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Jan;54(1):186-191. doi: 10.12182/20230160111. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36647665 Free PMC article. Chinese.
-
Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening to Helicobacter pylori Eradication in Korea.J Gastric Cancer. 2022 Jul;22(3):169-183. doi: 10.5230/jgc.2022.22.e22. J Gastric Cancer. 2022. PMID: 35938364 Free PMC article. Review.
References
-
- Kampschoer GH, Fujii A, Masuda Y. Gastric cancer detected by mass survey. Comparison between mass survey and outpatient detection. Scand J Gastroenterol. 1989;24:813–817. - PubMed
-
- Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean national cancer screening program in reducing gastric cancer mortality. Gastroenterology. 2017;152:1319–1328. e7. - PubMed
-
- Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–6740. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical